Navigation Links
Colitis More Common in Hospitalized Patients

According to a report in the July issue of Archives of Surgery,the rate of cases of colitis (colon inflammation) caused by the bacteria Clostridium difficile more than doubled among patients hospitalized in the United States between 1993 and 2003, and the illness was more severe and associated with an increased mortality rate.

C. difficile inhabits the intestines of approximately 1 percent to 3 percent of healthy adults and about 20 percent of patients receiving antibiotics, according to background information in the article.

When the balance of bacteria in the colon is altered, C. difficile can cause a variety of symptoms, including severe or complicated diarrhea that may eventually lead to death. Treatment for life-threatening forms of the disease usually involves colectomy, or removal of all or part of the colon, which is associated with a high rate of complications and high mortality.

Three million new cases of C. difficile colitis occur in the United States each year: as many as 10 percent of patients hospitalized for at least two days are affected, the authors write. Anecdotal evidence and some case series suggest that C. difficile colitis has become more common and potentially more pathogenic.

Rocco Ricciardi, M.D., M.P.H., then of the University of Minnesota Medical School, Minneapolis, and now of Lahey Clinic, Burlington. Mass., and colleagues analyzed discharge data from a database of U.S. hospitals between 1993 and 2003.

The database, the Nationwide Inpatient Sample, includes data from about 7 million hospital stays per year in 1,000 hospitals located in 35 states; thus, it approximates a 20 percent stratified sample of U.S. community hospitals, the authors write.

It provides information on patient demographics, socioeconomic factors, admission profiles, hospital profiles, state codes, discharge diagnoses, procedure codes, total charges and vital status at hospital discharge.

In th
'"/>




Page: 1 2 3 4

Related medicine news :

1. Bifidogenic Growth Stimulator: A Non-Toxic Way To Treat Ulcerative Colitis
2. Stubborn Ulcerative Colitis Responds to Arthritis Drug
3. Ulcerative Colitis Disrupts Many Aspects of Daily Life: Survey
4. Common contraception
5. Common Cold Remedy May Treat SARS
6. Common Plant Triggers Asthma
7. Pain Common in People with MS
8. Common Cold Found to Fight Cancer
9. Bullying – a Common Problem Among Childre
10. Common Medication Errors in Children
11. A Common Cause Of Allergy That Goes Unnoticed

Post Your Comments:
(Date:11/23/2009)...in Washington D.C. , NewYorkCity , LosAnge...cGrowthandRevitalization ,, WASHINGTON,Nov.23 ...ingproviderofdialysisservices,todaywaslaudedbyD.C....llioninvestmentinIndustrialBankaspartofaninitiativ...ta,sinvestmentinWashington,D.C.ispartofthedialysis...
(Date:11/23/2009)...upportsFutureLeadersinSTEMFields ,, Scholarsh... ceS c holars.org ,, WASHINGTON,Nov....ntusin.Withourcommunity,foundation,andcorporatepar...e,"saidAdolphP.Falcon,SeniorVicePresidentoftheNati...HousemeetingtodaywherePresidentObamaannouncedtheco...
(Date:11/23/2009)...wire-USNewswire/--SouthamptonHospitalannouncedtoda...anewEmergencyDepartment.ThegiftisthelargestintheHo...bletheexistingspaceandgreatlyexpanditsdeliveryofem...ongIsland. ,, ScheduledforcompletionbyMay2010, ...ideacentralizedtraumanurses,stationandtriagearea,e...
(Date:11/23/2009)...g, protein may be the cause , , MONDAY, ...they,ve identified a protein that causes nasal an...ple with chronic sinusitis. , The condition is ...tant irritation and swelling of the nasal passages...- can block the sinus passages and make it difficu...
(Date:11/23/2009)...nt Jennifer Heys wants to make her message clear: ...ities about contraception. , Heys, research, on... more children, was read by experts from all over ...nal Conference on Family Planning in Kampala, Ugan...Health, spent six months interviewing 421 people w...
Breaking Medicine News(10 mins):Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 2Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 3Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 4Health News:Alliance Joins President Obama at White House in Commitment to Science, Technology, Engineering, and Math (STEM) Education 2Health News:Southampton Hospital Receives $5 Million Gift for New Emergency Department 2Health News:Research Yields Clues to Severe Form of Sinusitis 2Health News:AIDS research reveals a lack of family-planning programs in Uganda 2
...discovery reveals a new cause of thyroid cancer. R...tumors, one of three genetic changes // happen. T...atients have not been exposed to radiation, the ch...e gene changes or mutations transform normal cells...
...ing to the Centers for Disease Control and Prevent...living with HIV.// Human Immuno Deficiency Virus ... Previous research has shown circumcised men ar...ey found each sample contained cells expressing th...
...nk between migraines and the risk of coronary hear...t study shows // no link between the two but does ...est pain, also known as angina. People with a h...port a history of chest pain than those without a ...
...chers now say they’ve found one drug that may succ...cancer.// For the study 22 patients with breast, p...r were involved , 42 percent had their tumors eith... so there’s much less side effects because it targ...
...study finds Alzheimer’s patients lose the ability ...sease progresses. // Researchers conducted a st... skills and Alzheimer’s disease. The study include... The study also included 23 healthy elderly people...
...chers say their discovery of a new compound known ...conjunction with // chemotherapy drugs such as cis...over 48 hours, small amounts of SP-4-84 made campt... caused by chemotherapeutic drugs. However, this w...
Other Medicine News:
(Date:11/23/2009)...v.23/PRNewswire-FirstCall/-- CumberlandPharmaceuti...neresultsfromastudyevaluatingthesafetyandefficacyo...spitalizedburnpatients. ,, Statisticalsignifica...inburnpatientsoverthefirst24hoursoftreatment.Thest...greeburnscoveringmorethan10percenttotalbodysurface...
(Date:11/23/2009)...Nov.23/PRNewswire/--Sarnova,Inc.,thenation,sleadin...gencymedicalservices(EMS)andrespiratorymarkets,ann...niormanagementteam.ThenewexecutivesincludeTomDavid...vicepresidentandgeneralcounsel;SteveLacke,executiv...ivevicepresidentofcorporatedevelopment. ,, "Iha...
(Date:11/23/2009)...23/PRNewswire/--ProteonTherapeutics,Inc.,hasinitia...-201,inend-stagerenaldisease(ESRD)patientsundergoi...studyrepresentsProteon,ssecondhumanclinicalstudyin...tionofaPhase1/2studyofPRT-201inESRDpatientsundergo...ierthisyear.Proteonalsoannouncestheappointmentofbo...
Breaking Medicine Technology:Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 3Sarnova Expands Senior Management Team 2Proteon Initiates Second Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients 2United Nations Secretary General Ban Ki moon to Keynote Rotary Internationals 100th Annual Meeting 49552 1United Nations Secretary General Ban Ki moon to Keynote Rotary Internationals 100th Annual Meeting 49552 2United Nations Secretary General Ban Ki moon to Keynote Rotary Internationals 100th Annual Meeting 49552 3Heart Attacks Less Often Fatal Today 49550 1Heart Attacks Less Often Fatal Today 49550 2Heart Attacks Less Often Fatal Today 49550 3Implanted defibrillators 3A New recommendations for drivers with ICDs 49548 1Implanted defibrillators 3A New recommendations for drivers with ICDs 49548 2
....m. today, Thursday, August 16, 2007, MALVERN, Pa...: AUXL ) today announced that the Company has,rec...stration ("FDA") to,resume its phase III clinical ...jection), formerly referred to as AA4500, in the t...ill hold a conference call today,August 16, at 10:...
...on on Track -, BRISBANE, Australia, Aug. 16 Prog...) today announced it has,executed an agreement wit...,Organisation, to utilise their services for a num...s agreement includes the execution of the,Phase 3 ...reatment of,primary liver cancer (hepatocellular c...
Other Medicine Technology:Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM) 2Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM) 3Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM) 4Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM) 5Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM) 6Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88 2Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88 3
Buffered Wright-Giemsa Stain
Giemsa Stain
Albumin (BCP)
Albumin Reagent Set
Medicine Products: